The Biotech CFO: Excel Meets Enzymes

The Biotech CFO: Where Excel Meets Enzymes

People often assume that being a CFO is the same across every industry. You wear a suit, you love spreadsheets, and you say "No" a lot. But being a CFO in biotech? That is a different beast entirely.

In software, you worry about user churn. In retail, you worry about inventory. In biotech, I spend my Tuesday mornings worrying if a specific strain of mice is happy enough to reproduce.

The Art of the "Scientific" Forecast

My job is essentially translating "we have a hunch this molecule works" into "here is a five-year revenue projection." It requires a specific kind of creativity—the kind where you have to explain to a room full of investors why our burn rate is high (science is expensive) but our revenue is zero (science is slow).

Here are a few things I never thought I’d say in a finance meeting until I joined this industry:

• "We need to increase the budget for centrifuge maintenance."
• "No, we cannot 'growth hack' FDA Phase II clinical trials."
• "The asset isn't depreciating; it's currently frozen in liquid nitrogen."

It’s a balancing act between the rigid logic of a balance sheet and the chaotic, beautiful uncertainty of biology.

And honestly? I wouldn't trade it for a SaaS company in a million years. Someone has to keep the lights on while the scientists figure out how to save the world. I just make sure we can afford the electricity bill.